Skip to content

908 Devices MASS Return on equity

Return on equity at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
13.5%-0.2pp
WAT
Waters CorporationWAT
5.2%-35.6pp
Agilent Technologies logo
Agilent TechnologiesA
21.3%+2.4pp
Bruker logo
BrukerBRKR
-1%-21.2pp
Danaher logo
DanaherDHR
7.1%-0.1pp
Idexx Laboratories logo
Idexx LaboratoriesIDXX
72.9%+13.6pp

Other financials

Income statement

See full
Revenue$13.4M+13.6%
Gross profit$6.9M+24.2%
Operating income-$12.9M-16.9%
Net income-$12.0M-127%
EPS (diluted)-$0.32-126%

Balance sheet

See full
Cash & equivalents$67.6M-14.7%
Total debt$4.5M+18.6%
Total equity$134.2M-15.8%
Total assets$186.7M-4.8%

Cash flow

See full
Operating cash flow$1.2M+108%
CapEx$40.0K-74.8%
Free cash flow$1.2M+108%

Valuation

See full
Market cap$339.57M+29.0%
Enterprise value$276.47M+47.2%
P/S5.9×+0.8×

Profitability

See full
Gross margin51.5%+1.3pp
Operating margin-76.8%-19.6pp
Net margin-62.4%+323pp
FCF margin-16.7%-7.2pp

Returns & leverage

See full
Debt / equity0.0×
Current ratio3.6×-4.0×

Where this comes from

Calculated from 908 Devices’s reported figures.

Based on trailing twelve months.

The official record: 908 Devices’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about 908 Devices's return on equity.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is 908 Devices's return on equity?
908 Devices (MASS) reported return on equity of -24.6% in Q1 2026.
How has 908 Devices's return on equity changed year-over-year?
908 Devices's return on equity decreased by 119.7% year-over-year, from -11.2% to -24.6%.
What is the long-term trend for 908 Devices's return on equity?
Over 4 years (2021 to 2025), 908 Devices's return on equity has grown at a 4.7% compound annual growth rate (CAGR), from -12.5% to 15.1%.
What does return on equity mean?
Trailing-twelve-month net income divided by average shareholders' equity (average of the start and end of the trailing-twelve-month window). Measures the profit generated on each dollar of shareholder capital.